Pharma Marketing News
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Conference Calendar Reader Surveys

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
Share |

FDA's Regulation of Drug & Device Promotion via the Internet & Social Media
Special Report: Summary of Reader Survey

FDA SM Solar SystemOn September 21, 2009, the FDA issued a notice of public hearing and requested for comments on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. Public Docket No. FDA-2009-N-0441, CDER 200994, was opened and accepted comments through February 28, 2010.

The FDA asked for comments relating to the following 5 issues:

  • Issue 1: Accountability
  • Issue 2: Fulfilling Regulatory Requirements
  • Issue 3: Posting Corrective Information
  • Issue 4: Links
  • Issue 5: Adverse Event Reporting
Under each issue, the FDA included several specific questions for which it was seeking answers. Beginning on September 21, 2009, Pharma Marketing News hosted an online survey/questionnaire that included all 19 of these specific questions. For most questions, the survey included specific choices that respondents could select as part of their answer. Each question also allowed respondents to enter comments. The goal of was to obtain both quantitative and qualitative answers to the questions posed by the FDA.

The survey was closed on February 26, 2010 after collecting responses from 274 people. A summary of the results--including 731 comments--is presented in this report.

Read this article now. It's FREE...

Download PDF file

Published February 2010

Find other articles in related Topic Areas:

More Content

Search All Pharma Marketing News Pages

Pharma Marketing News Email Addr:  

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.